Open AccessProlonged Diarrhea Due to Ciprofloxacin‐ResistantCampylobacterInfection
Author(s) -
Jennifer Nelson,
Kirk Smith,
Duc J. Vugia,
Therese RabatskyEhr,
Suzanne Segler,
Heidi Kassenborg,
Shelley M. Zansky,
Kevin Joyce,
Nina Marano,
Robert M. Hoekstra,
Frederick J. Angulo
Publication year - 2004
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/423282
Subject(s) - ciprofloxacin , campylobacter , diarrhea , medicine , antimicrobial , microbiology and biotechnology , biology , antibiotics , bacteria , genetics
Campylobacter causes >1 million infections annually in the United States. Fluoroquinolones (e.g., ciprofloxacin) are used to treat Campylobacter infections in adults. Although human infections with ciprofloxacin-resistant Campylobacter have become increasingly common, the human health consequences of such infections are not well described.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom